AI technology is real but its current valuations are inflated, resembling past market bubbles. Investors are urged to avoid the fear of mis...

America has started a trade probe into Germany's plan to cut pharmaceutical spending. U.S. Trade Representative Jamieson Greer stated the i...

Financial stocks are set to lead a market rally through June and July. Experts see banks and financial institutions benefiting from strong ...

India's long-term growth outlook remains robust despite global geopolitical uncertainties and intermittent market volatility, supported by ...

Indian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...

Foreign institutional investors have sold Indian stocks worth Rs 5.5 lakh crore. However, a hidden list reveals 84 stocks where FIIs have a...

The Northeast region of India has transformed into a major economic growth hub; significant investments in infrastructure, digital connecti...

It has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...

Gujarat is set to launch its Industrial Policy 2026 on June 15, aiming to accelerate growth, attract investments, and foster innovation. Th...

With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...

India is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...

As artificial intelligence grows more powerful, governments must move beyond transparency measures and introduce stronger regulations to ad...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...

George Heber Joseph of ASK Investment Managers believes Indian markets have entered a stock pickers’ phase as RBI flags inflation and growt...

Indian diaspora groups in the US have lauded a federal court's decision to strike down the $100,000 H-1B visa fee, deeming it a fair move f...

US lawmakers welcomed a court ruling blocking a proposed USD 100,000 H-1B visa fee, despite White House plans to appeal. The decision cruci...